Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

SHA:600721 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	29.96	40.69	41.48	12.97	-34.76	59.83
Depreciation & Amortization	18.58	17.89	18.58	23.15	26.16	25.14
Other Amortization	1.38	1.83	1.8	1.89	2	2
Loss (Gain) From Sale of Assets	-0	-0	-0.09	-0.01	-0	-0
Asset Writedown & Restructuring Costs	7.87	1.01	0.22	-0.31	-0.71	-2.4
Loss (Gain) From Sale of Investments	6.67	6.56	-3.5	-1.25	0.77	2.09
Provision & Write-off of Bad Debts	-6.39	4.52	27.95	16.46	16.53	8.72
Other Operating Activities	18.14	23.1	32.02	37.17	43.07	11.44
Change in Accounts Receivable	-30.01	-58.95	-1.01	-34.26	-49.84	7.01
Change in Inventory	43.3	46.27	-7.49	4.21	2.5	-16.72
Change in Accounts Payable	-53.95	-51.38	-13.08	-4.05	37.01	-67.97
Change in Other Net Operating Assets	-	-	-1.08	3.25	7.99	2.4
Operating Cash Flow	33.85	30.42	80.29	62.08	53.18	34.72
Operating Cash Flow Growth	53.31%	-62.11%	29.33%	16.74%	53.15%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-11.6	-18	-24.61	-17.24	-2.41	-6.04
Sale of Property, Plant & Equipment	0.06	0.06	0.07	0.02	0.02	0
Cash Acquisitions	-	-	-	-	-4.9	-
Investment in Securities	-81.4	-3.8	-	-	-4	6
Other Investing Activities	2.87	2.53	2.47	1.57	0.73	0.33
Investing Cash Flow	-90.07	-19.2	-22.08	-15.65	-10.56	0.3

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	-	-	-	-	6.29
Total Debt Issued	20	-	-	-	-	6.29
Short-Term Debt Repaid	-	-	-	-	-6.29	-
Total Debt Repaid	-20	-	-	-	-6.29	-
Net Debt Issued (Repaid)	-	-	-	-	-6.29	6.29
Issuance of Common Stock	1.26	2.56	11.77	19.91	12.64	-
Common Dividends Paid	-15.46	-	-	-	-0.12	-0.04
Financing Cash Flow	-14.2	2.56	11.77	19.91	6.23	6.25

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	-70.42	13.78	69.98	66.34	48.85	41.27

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	22.25	12.42	55.68	44.84	50.77	28.68
Free Cash Flow Growth	347.02%	-77.69%	24.18%	-11.68%	77.01%	-
Free Cash Flow Margin	6.48%	3.20%	14.44%	12.14%	14.51%	10.20%
Free Cash Flow Per Share	0.06	0.03	0.15	0.12	0.14	0.08
Levered Free Cash Flow	32.05	15.27	66.32	46.43	65.6	-24.76
Unlevered Free Cash Flow	32.05	15.27	66.32	46.43	65.67	-24.73

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	21.19	17.52	14.12	11.79	5.07	8.42
Change in Working Capital	-42.36	-65.18	-38.18	-27.98	0.12	-72.09

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error